Ayrton I Bangolo

26PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jun 26, 2026
Combined Immune Checkpoint Inhibitors and Radiation Therapy in Patients with Multiple Myeloma and Extramedullary Medullary Disease: A Real-World Retrospective Analysis.

|Aug 27, 2025
Ten-Year Trends in Hepatocellular Carcinoma Mortality: Examining the Interaction Between Fibrosis Score and Patient Age.

Ayrton Bangolo, Hadrian Hoang-Vu Tran, Budoor Alqinai

|Jul 29, 2025
Engineering Innate Immunity: Recent Advances and Future Directions for CAR-NK and CAR-Macrophage Therapies in Solid Tumors.

Behzad Amoozgar, Ayrton Bangolo, Charlene Mansour

|Jul 29, 2025
JAK2 Inhibitors and Emerging Therapies in Graft-Versus-Host Disease: Current Perspectives and Future Directions.

Behzad Amoozgar, Ayrton Bangolo, Abdifitah Mohamed

|Jun 13, 2025
From Molecular Precision to Clinical Practice: A Comprehensive Review of Bispecific and Trispecific Antibodies in Hematologic Malignancies.

Behzad Amoozgar, Ayrton Bangolo, Maryam Habibi

|Feb 25, 2025
Age and Tumor Stage Interplay in Intrahepatic Cholangiocarcinoma: Prognostic Factors, Mortality Trends, and Therapeutic Implications from a SEER-Based Analysis.

Ayrton Bangolo, Vignesh K Nagesh, Hadrian Hoang-Vu Tran

Pageof 5

Frequent Collaborators

4 joint publications

Lili Zhang

3 joint publications

John Kakamba Bukasa

3 joint publications

Pierre Fwelo

3 joint publications

Vignesh Krishnan Nagesh